BackAdverum Biotechnologies Overview

Adverum Biotechnologies Inventory

Adverum Biotechnologies's inventory is $0.

Get informed when a big investor buys or sells

+ Follow
Inventory
$0.00

Peer trimmed avg / median

Loading

Adverum Biotechnologies Inventory History

Loading

Adverum Biotechnologies vs. peers: Inventory Comparison

Loading

Adverum Biotechnologies Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Adverum Biotechnologies (ADVM) FAQ

As of the most recent data (September 2025), ADVM shows a inventory of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADVM's inventory is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Adverum Biotechnologies is outperforming or lagging.

Tracking ADVM's inventory over time shows whether Adverum Biotechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Adverum Biotechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $0) with ownership activity and broader fundamentals.

Adverum Biotechnologies's inventory is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.